CIK 0001082554
- Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 521984749
- Phone
- +1 301-608-9292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $344,206,005
- in 74 filings, $343.4M under 10b5-1 plans
Net −$344,206,005. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-17 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion 10b5-1 | +11,000 | $117.76 | $1.3M | 47,781 |
| 2025-04-17 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −400 | $280.35 | $112K | 47,381 |
| 2025-04-17 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,016 | $282.92 | $570K | 45,365 |
| 2025-04-17 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −5,488 | $283.83 | $1.6M | 39,877 |
| 2025-04-17 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −3,096 | $284.69 | $881K | 36,781 |
| 2025-04-17 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion · Stock Option 10b5-1 | −11,000 | 26,000 | ||
| 2025-04-14 | DWEK RAYMOND Director | Exercise or conversion 10b5-1 | +3,000 | $175.43 | $526K | 4,750 |
| 2025-04-14 | DWEK RAYMOND Director | Sale 10b5-1 | −3,000 | $285.16 | $855K | 1,750 |
| 2025-04-14 | DWEK RAYMOND Director | Exercise or conversion · Stock Option 10b5-1 | −3,000 | 3,000 | ||
| 2025-04-07 | DWEK RAYMOND Director | Exercise or conversion 10b5-1 | +4,000 | $175.43 | $702K | 5,750 |
| 2025-04-07 | DWEK RAYMOND Director | Sale 10b5-1 | −4,000 | $284.55 | $1.1M | 1,750 |
| 2025-04-07 | DWEK RAYMOND Director | Exercise or conversion · Stock Option 10b5-1 | −4,000 | 6,000 | ||
| 2025-04-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion 10b5-1 | +11,000 | $117.76 | $1.3M | 47,781 |
| 2025-04-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −200 | $298.00 | $60K | 47,581 |
| 2025-04-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −200 | $300.42 | $60K | 47,381 |
| 2025-04-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −3,094 | $305.08 | $944K | 44,287 |
| 2025-04-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,218 | $306.08 | $679K | 42,069 |
| 2025-04-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −3,787 | $307.12 | $1.2M | 38,282 |
| 2025-04-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,501 | $308.08 | $462K | 36,781 |
| 2025-04-03 | MAHON PAUL A EVP & GENERAL COUNSEL | Exercise or conversion · Stock Option 10b5-1 | −11,000 | 37,000 |
Page 213 of 214 · 4,273 trades